WASHINGTON, April 29 /PRNewswire/ -- VA's Office of Research and Development is at the forefront of developing safer, more effective treatments based on new knowledge about the role of genes in health and disease. VA is superbly fitted to study genomics--the use of patients' individual genetic profiles to customize care--because of its genomics laboratory; large and diverse patient population; world-class investigators; an integrated network of basic research and clinical application; and an unequaled electronic medical record system that will in time incorporate genetic information.
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/veteransgenomics/38100/
"The future of medicine is determined by research. And genomics is the direction for research in the 21st century," says Joel Kupersmith, M.D., VA's Chief Research and Development Officer. Genomics is the key, Kupersmith elaborates, to personalizing medicine--that is, tailoring disease screening, treatment, and monitoring according to an individual patient's genetic makeup.
Genomics-based approaches currently in use at the VA include genetic tests to confirm the diagnosis of hemochromatosis, a hereditary condition in which iron builds up in the body; to predict a patient's response to cholesterol-lowering statin drugs; and to help diagnose breast, colon, and other cancers.
VA Research has a rich array of ongoing genomics studies. At the Washington D.C. VA Medical Center, for example, a clinical research team led by Jack Lichy, M.D., Ph.D., is examining the genetic factors in the treatment of bladder and colon cancers. The investigators are also working to predict adverse reactions to a drug commonly used to prevent dangerous blood clots.
"What we're learning," says Marc Blackman, M.D., Associate Chief of
|SOURCE Department of Veterans Affairs|
Copyright©2009 PR Newswire.
All rights reserved